Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women

Strickler, H. D., Palefsky, J. M., Shah, K. V., Anastos, K., Klein, R. S., Minkoff, H., Duerr, A., Massad, L. S., Celentano, D. D., Hall, C., Fazzari, M., Cu-Uvin, S., Bacon, M., Schuman, P., Levine, A. M., Durante, A. J., Gange, S., Melnick, S., Burk, R. D.·2003·JNCI Journal of the National Cancer Institute

Abstract

BACKGROUND: Human papillomavirus (HPV) type 16 is etiologically associated with approximately half of all cervical cancers. It is important, therefore, to determine the characteristics that distinguish HPV16 from other HPV types. A preliminary result based on cross-sectional baseline data in the Women's Interagency Human Immunodeficiency Virus (HIV) Study (WIHS) suggested that the prevalence of HPV16 might have a weaker association with immune status in HIV-seropositive women than that of other HPV types. To address this issue, we examined HPV test results from repeated study visits in the WIHS and from an independent study, the HIV Epidemiology Research Study (HERS). METHODS: HIV-seropositive women in the WIHS (n = 2058) and in the HERS (n = 871) were assessed semiannually. HPV DNA was detected in cervicovaginal lavage specimens by using polymerase chain reaction assays. Prevalence ratios were used to compare the prevalence of each HPV type in women with the lowest CD4+ T-cell counts (<200 T cells/mm3) with that of women with the highest CD4+ T-cell counts (> or =500 T cells/mm3). A summary prevalence ratio for each HPV type (i.e., across visits and studies) was estimated using generalized estimating equations. The association of CD4+ T-cell stratum with type-specific HPV incidence was measured using multivariable Cox regression models. All statistical tests were two-sided. RESULTS: The prevalence ratio for HPV16 was low compared with that of other HPV types at every study visit in both cohorts. The generalized estimating equation summary prevalence ratio for HPV16 (1.25, 95% confidence interval [CI] = 0.97 to 1.62) was the smallest measured, and it was statistically significantly lower than that of all other HPV types combined (P =.01). The association of CD4+ T-cell stratum with HPV16 incidence was also among the smallest measured (hazard ratio = 1.69, 95% CI = 1.01 to 2.81). CONCLUSIONS: The prevalent and incident detection of HPV16 is more weakly associated with immune status in HIV-seropositive women than that of other HPV types, suggesting that HPV16 may be better at avoiding the effects of immune surveillance, which could contribute to HPV16's strong association with cervical cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/95.14.1062

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 216

Metadata

Authors
Strickler, H. D., Palefsky, J. M., Shah, K. V., Anastos, K., Klein, R. S., Minkoff, H., Duerr, A., Massad, L. S., Celentano, D. D., Hall, C., Fazzari, M., Cu-Uvin, S., Bacon, M., Schuman, P., Levine, A. M., Durante, A. J., Gange, S., Melnick, S., & Burk, R. D.
Venue
JNCI Journal of the National Cancer Institute
Published
2003-07-15
Volume
95
Issue
14
Pages
1062-1071
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W1973422557
Cited by
216
References
2
FWCI
6.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women. https://app.cochat.ai/papers/10.1093/jnci/95.14.1062
The paper
Strickler, H. D., Palefsky, J. M., Shah, K. V., Anastos, K., Klein, R. S., Minkoff, H., Duerr, A., Massad, L. S., Celentano, D. D., Hall, C., Fazzari, M., Cu-Uvin, S., Bacon, M., Schuman, P., Levine, A. M., Durante, A. J., Gange, S., Melnick, S., & Burk, R. D. (2003). Human Papillomavirus Type 16 and Immune Status in Human Immunodeficiency Virus-Seropositive Women. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/95.14.1062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.